Skip to main content

An Effective Immunosuppressant with Significant Safety Considerations: Pharmacists Guide to Safe Use of Mycophenolate

Tracking # 20-1315049

Free

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

The goal of this educational activity is to educate pharmacists in all practice settings nationwide on the mechanism and uses of mycophenolate, the risks associated with using the drug in females of reproductive potential, and the importance of adherence to the Mycophenolate REMS program to improve safe use of the drug.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Pharmacy

Pharmacist

1h General

Disclosure statements

Dr. Enderby has no relevant affiliations or financial relationships with a commercial interest to disclose.

Dr. Chandran has disclosed that she has received honoraria for non-CME related activities from Eurofins Viracor.

The clinical reviewer, Lisa Holle, PharmD, BCOP, FHOPA, has disclosed that she has no relevant affiliations or financial relationships with a commercial interest to disclose.

Susanne Kwas, MSHF, BSN, RN, Robin Soboti, RPh, and Susan R. Grady, MSN, RN as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

All relevant financial relationships have been mitigated.